Siloton funding

Siloton, the Bristol-based health technology start-up, has secured £860,000 to progress the commercial roll-out of its groundbreaking eye imaging chip technology, which could help address the UK’s most common cause of sight loss.

Evenlode Impact Investments committed further capital in the latest round alongside members of the South East Angels, the Francis Crick Institute, and other experienced angel investors. They were complemented by non-dilutive funding from an Innovate UK Biomedical Catalyst grant, taking total funding in the company to date to £1.7 million.

Charles van der Lande of Roxburgh Milkins advised Siloton.

Find out more about the deal: Siloton Second Round — Siloton Limited.

Find out more about our work with Siloton: Client Story